Attenuation of sensory afferent nerve firing by brefeldin-A in an ex vivo mouse bladder model

Valerie M. Collins; Christopher R. Chapple; Neil G. McKay; Donna J Sellers; David Grundy

doi:10.1016/S1569-9056(10)60131-5

Attenuation of sensory afferent nerve firing by brefeldin-A in an ex vivo mouse bladder model

Valerie M. Collins
, Christopher R. Chapple
, Neil G. McKay
, Donna J Sellers
, David Grundy

Research output: Contribution to journal › Meeting Abstract › Research

Abstract

Urinary urgency is the key sensory symptom of overactive bladder syndrome (OABS). In recent years, injection of botulinum toxin type A (BoNT/A) into the bladder has proved to be an effective way of treating urgency in patients with OABS.
However, the underlying mechanism of action of BoNT/A is unclear. It has been suggested that the efficacy of BoNT/A may
depend on inhibition of vesicular release of neurotransmitters and mediators from suburothelial nerves and/or the urothelium.

Original language	English
Article number	126
Pages (from-to)	72-72
Number of pages	1
Journal	European Urology, Supplements
Volume	9
Issue number	2
DOIs	https://doi.org/10.1016/S1569-9056(10)60131-5
Publication status	Published - 2010
Externally published	Yes

Access to Document

10.1016/S1569-9056(10)60131-5

Cite this

@article{8ecfd4eeecbf4e2ea95c184a93f3b071,

title = "Attenuation of sensory afferent nerve firing by brefeldin-A in an ex vivo mouse bladder model",

abstract = "Urinary urgency is the key sensory symptom of overactive bladder syndrome (OABS). In recent years, injection of botulinum toxin type A (BoNT/A) into the bladder has proved to be an effective way of treating urgency in patients with OABS. However, the underlying mechanism of action of BoNT/A is unclear. It has been suggested that the efficacy of BoNT/A may depend on inhibition of vesicular release of neurotransmitters and mediators from suburothelial nerves and/or the urothelium.",

author = "Collins, \{Valerie M.\} and Chapple, \{Christopher R.\} and McKay, \{Neil G.\} and Sellers, \{Donna J\} and David Grundy",

year = "2010",

doi = "10.1016/S1569-9056(10)60131-5",

language = "English",

volume = "9",

pages = "72--72",

journal = "European Urology, Supplements",

issn = "1569-9056",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Attenuation of sensory afferent nerve firing by brefeldin-A in an ex vivo mouse bladder model

AU - Collins, Valerie M.

AU - Chapple, Christopher R.

AU - McKay, Neil G.

AU - Sellers, Donna J

AU - Grundy, David

PY - 2010

Y1 - 2010

N2 - Urinary urgency is the key sensory symptom of overactive bladder syndrome (OABS). In recent years, injection of botulinum toxin type A (BoNT/A) into the bladder has proved to be an effective way of treating urgency in patients with OABS. However, the underlying mechanism of action of BoNT/A is unclear. It has been suggested that the efficacy of BoNT/A may depend on inhibition of vesicular release of neurotransmitters and mediators from suburothelial nerves and/or the urothelium.

AB - Urinary urgency is the key sensory symptom of overactive bladder syndrome (OABS). In recent years, injection of botulinum toxin type A (BoNT/A) into the bladder has proved to be an effective way of treating urgency in patients with OABS. However, the underlying mechanism of action of BoNT/A is unclear. It has been suggested that the efficacy of BoNT/A may depend on inhibition of vesicular release of neurotransmitters and mediators from suburothelial nerves and/or the urothelium.

U2 - 10.1016/S1569-9056(10)60131-5

DO - 10.1016/S1569-9056(10)60131-5

M3 - Meeting Abstract

SN - 1569-9056

VL - 9

SP - 72

EP - 72

JO - European Urology, Supplements

JF - European Urology, Supplements

IS - 2

M1 - 126

ER -

Attenuation of sensory afferent nerve firing by brefeldin-A in an ex vivo mouse bladder model

Abstract

Access to Document

Fingerprint

Cite this